APA (7th ed.) Citation

Feldt-Rasmussen, U., Hughes, D., Sunder-Plassmann, G., Shankar, S., Nedd, K., Olivotto, I., . . . Nicholls, K. (2020). Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study. Molecular Genetics & Metabolism, 131(1/2), 219. https://doi.org/10.1016/j.ymgme.2020.07.007

Chicago Style (17th ed.) Citation

Feldt-Rasmussen, Ulla, et al. "Long-term Efficacy and Safety of Migalastat Treatment in Fabry Disease: 30-month Results from the Open-label Extension of the Randomized, Phase 3 ATTRACT Study." Molecular Genetics & Metabolism 131, no. 1/2 (2020): 219. https://doi.org/10.1016/j.ymgme.2020.07.007.

MLA (9th ed.) Citation

Feldt-Rasmussen, Ulla, et al. "Long-term Efficacy and Safety of Migalastat Treatment in Fabry Disease: 30-month Results from the Open-label Extension of the Randomized, Phase 3 ATTRACT Study." Molecular Genetics & Metabolism, vol. 131, no. 1/2, 2020, p. 219, https://doi.org/10.1016/j.ymgme.2020.07.007.